Achilles Therapeutics Plc - ADR

NASDAQ:ACHL   3:59:54 PM EDT
4.92
+0.08 (+1.65%)
Earnings Announcements

Achilles Therapeutics Reports Third Quarter 2021 Financial Results And Recent Business Highlights

Published: 11/09/2021 13:51 GMT
Achilles Therapeutics Plc - ADR (ACHL) - Achilles Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights.
Achilles Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights.
Qtrly Net Loss per Share Attributable to Ordinary Shareholders Basic and Diluted $0.34.
Anticipates Cash and Cash Equivalents Are Sufficient to Fund Planned Operations Into Second Half of 2023.
Q3 Earnings per Share View $-0.48 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.41

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.